Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018

SELL
$10.79 - $24.44 $129,479 - $293,280
-12,000 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$9.0 - $20.16 $108,000 - $241,920
12,000 New
12,000 $134,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $684M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.